Celldex Therapeutics, CuraGen shareholders to vote on merger Sept. 30

By Lisa Kerner

Charlotte, N.C., Aug. 28 - Shareholders of Celldex Therapeutics, Inc. and CuraGen Corp. will be asked to approve the biopharmaceutical companies' merger at separate special meetings at 5 p.m. ET on Sept. 30.

The record date is Aug. 17 for the CuraGen meeting and Aug. 20 for the Celldex meeting, according to a 424B3 filing with the Securities and Exchange Commission.

In May, Bloomsbury, N.J.-based Celldex announced it will acquire CuraGen, located in Branford, Conn., in an all-stock deal valued at $94.5 million.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.